Stock Events

Stock Events

KalVista Pharmaceuticals (4XC1.F) Q3 2024 Earnings

5SepConfirmed

Q3 2023

Q1 2024

Q3 2024

Q3 2024

-0.94

-0.84

-0.75

-0.66

Details

Expected EPS

-0.8234817

Actual EPS

-0.7829826

Surprise EPS

0.04

Surprise Percent

+4.92%

Description

KalVista Pharmaceuticals (4XC1.F) has reported earnings of -0.7829826 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.